The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Bacterial Biofilm Eradication Agents: A Current Review
Open accessAbstract
Most free-living bacteria can attach to surfaces and aggregate to grow into multicellular communities encased in extracellular polymeric substances called biofilms. Biofilms are recalcitrant to antibiotic therapy and a major cause of persistent and recurrent infections by clinically important pathogens worldwide (e.g., Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus). Currently, most biofilm remediation strategies involve the development of biofilm-inhibition agents, aimed at preventing the early stages of biofilm formation, or biofilm-dispersal agents, aimed at disrupting the biofilm cell community. While both strategies offer some clinical promise, neither represents a direct treatment and eradication strategy for established biofilms. Consequently, the discovery and development of biofilm eradication agents as comprehensive, stand-alone biofilm treatment options has become a fundamental area of research. Here we review our current understanding of biofilm antibiotic tolerance mechanisms and provide an overview of biofilm remediation strategies, focusing primarily on the most promising biofilm eradication agents and approaches. Many of these offer exciting prospects for the future of biofilm therapeutics for the large number of infections that are currently refractory to conventional antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,158
Bacterial Biofilms in Nature and Disease
Costerton, J. W., Cheng, K. J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M., & Marrie, T. J. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.002251 · Cited by 3,145
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
The EPS Matrix: The “House of Biofilm Cells”
Flemming, H.-C., Neu, T. R., & Wozniak, D. J. (2007) · Journal of Bacteriology · doi:10.1128/jb.00858-07 · Cited by 1,794
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
James, G. A., Swogger, E., Wolcott, R., Pulcini, E. D., Secor, P., Sestrich, J., Costerton, J. W., & Stewart, P. S. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00321.x · Cited by 1,543
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Bacterial adhesion: seen any good biofilms lately
Dunne, W. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.155-166.2002 · Cited by 1,516
Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential
Desbois, A. P., & Smith, V. J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2355-3 · Cited by 1,442
Mechanisms of antibiotic resistance in bacterial biofilms
Stewart, P. S. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00196 · Cited by 1,385
A review of the biomaterials technologies for infection-resistant surfaces
Campoccia, D., Montanaro, L., & Arciola, C. R. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.089 · Cited by 1,358
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
A review of current and emergent biofilm control strategies
Simões, M., Simões, L. C., & Vieira, M. J. (2010) · LWT - Food Science and Technology · doi:10.1016/j.lwt.2009.12.008 · Cited by 1,231
Laboratory of Biomechanics and Biomedical Engineering, D. O. M. E., Katsikogianni, M., & Missirlis, Y. (2004) · European Cells and Materials · doi:10.22203/ecm.v008a05 · Cited by 1,178
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Persister cells and tolerance to antimicrobials
Keren, I., Kaldalu, N., Spoering, A., Wang, Y., & Lewis, K. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00856-5 · Cited by 1,098
Arciola, C. R., Campoccia, D., Speziale, P., Montanaro, L., & Costerton, J. W. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.031 · Cited by 1,047
Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.317-323.2003 · Cited by 988
Pathogenesis of Methicillin‐Resistant Staphylococcus aureus Infection
Gordon, R. J., & Lowy, F. D. (2008) · Clinical Infectious Diseases · doi:10.1086/533591 · Cited by 961
Anderl, J. N., Franklin, M. J., & Stewart, P. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1818-1824.2000 · Cited by 958
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal
McDougald, D., Rice, S. A., Barraud, N., Steinberg, P. D., & Kjelleberg, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2695 · Cited by 881
Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coli
Keren, I., Shah, D., Spoering, A., Kaldalu, N., & Lewis, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8172-8180.2004 · Cited by 856
Cationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Involvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa
Barraud, N., Hassett, D. J., Hwang, S.-H., Rice, S. A., Kjelleberg, S., & Webb, J. S. (2006) · Journal of Bacteriology · doi:10.1128/jb.00779-06 · Cited by 783
Multi-species biofilms: living with friendly neighbors
Elias, S., & Banin, E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00325.x · Cited by 762
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
Bacterial Persister Cell Formation and Dormancy
Wood, T. K., Knabel, S. J., & Kwan, B. W. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.02636-13 · Cited by 703
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
The role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
Yoon, B., Jackman, J., Valle-González, E., & Cho, N.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041114 · Cited by 637
Quinoline Antimalarials Mechanisms of Action and Resistance and Prospects for New Agents
Foley, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00012-6 · Cited by 592
Mitomycin C: small, fast and deadly (but very selective)
Tomasz, M. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90120-5 · Cited by 581
Beloin, C., Roux, A., & Ghigo, J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_12 · Cited by 578
Resistance of bacterial biofilms to antibiotics a growth-rate related effect?
BROWN, M. R. W., ALLISON, D. G., & GILBERT, P. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.6.777 · Cited by 545
Eastman, A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90009-x · Cited by 539
Persister cells and the riddle of biofilm survival
Lewis, K. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0111-6 · Cited by 520
High Rates of Conjugation in Bacterial Biofilms as Determined by Quantitative In Situ Analysis
Hausner, M., & Wuertz, S. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.8.3710-3713.1999 · Cited by 486
Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Prevention and control of biofilm-based medical-device-related infections
Francolini, I., & Donelli, G. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00665.x · Cited by 470
Observations on the Mechanism of Action of Penicillin.
Hobby, G. L., Meyer, K., & Chaffee, E. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-50-13773 · Cited by 444
Innate and Induced Resistance Mechanisms of Bacterial Biofilms
Anderson, G. G., & O'Toole, G. A. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_5 · Cited by 438
Russell, A. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00833-8 · Cited by 419
The Evolution of Quorum Sensing in Bacterial Biofilms
Nadell, C. D., Xavier, J. B., Levin, S. A., & Foster, K. R. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060014 · Cited by 409
Action of Disinfectant Quaternary Ammonium Compounds against Staphylococcus aureus
Ioannou, C. J., Hanlon, G. W., & Denyer, S. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00375-06 · Cited by 377
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
Rachid, S., Ohlsen, K., Witte, W., Hacker, J., & Ziebuhr, W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3357-3363.2000 · Cited by 373
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Penesyan, A., Gillings, M., & Paulsen, I. (2015) · Molecules · doi:10.3390/molecules20045286 · Cited by 363
Quorum sensing and bacterial biofilms
Dickschat, J. S. (2010) · Natural Product Reports · doi:10.1039/b804469b · Cited by 355
Anderl, J. N., Zahller, J., Roe, F., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1251-1256.2003 · Cited by 355
Microbial Biofilms and Chronic Wounds
Omar, A., Wright, J., Schultz, G., Burrell, R., & Nadworny, P. (2017) · Microorganisms · doi:10.3390/microorganisms5010009 · Cited by 348
Mitomycin C: a clinical update
Bradner, W. T. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0202 · Cited by 346
Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E. P., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1175-1187.2004 · Cited by 345
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Approaches to Dispersing Medical Biofilms
Fleming, D., & Rumbaugh, K. (2017) · Microorganisms · doi:10.3390/microorganisms5020015 · Cited by 329
Periodontal-disease-associated biofilm: A reservoir for pathogens of medical importance
Vieira Colombo, A. P., Magalhães, C. B., Hartenbach, F. A. R. R., Martins do Souto, R., & Maciel da Silva-Boghossian, C. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.09.009 · Cited by 322
Small molecule control of bacterial biofilms
Worthington, R. J., Richards, J. J., & Melander, C. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25835h · Cited by 299
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Bacterial community morphogenesis is intimately linked to the intracellular redox state
Dietrich, L. E. P., Okegbe, C., Price-Whelan, A., Sakhtah, H., Hunter, R. C., & Newman, D. K. (2013) · Journal of Bacteriology · doi:10.1128/jb.02273-12 · Cited by 291
Barraud, N., Storey, M. V., Moore, Z. P., Webb, J. S., Rice, S. A., & Kjelleberg, S. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2009.00098.x · Cited by 289
P. aeruginosa Biofilms in CF Infection
Wagner, V. E., & Iglewski, B. H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8079-9 · Cited by 288
Microbial Biofilms: Their Development and Significance for Medical Device—Related Infections
Habash, M., & Reid, G. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008506 · Cited by 287
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 287
Agents that Inhibit Bacterial Biofilm Formation
Rabin, N., Zheng, Y., Opoku-Temeng, C., Du, Y., Bonsu, E., & Sintim, H. O. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.7 · Cited by 273
Interactions between Biocide Cationic Agents and Bacterial Biofilms
Campanac, C., Pineau, L., Payard, A., Baziard-Mouysset, G., & Roques, C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1469-1474.2002 · Cited by 263
Antimicrobial lipids: Natural and synthetic fatty acids and monoglycerides
Kabara, J. J., Vrable, R., & Lie Ken Jie, M. S. F. (1977) · Lipids · doi:10.1007/bf02570908 · Cited by 257
Nitric Oxide: A Key Mediator of Biofilm Dispersal with Applications in Infectious Diseases
Barraud, N., Kelso, M., Rice, S., & Kjelleberg, S. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905112822 · Cited by 255
Gordon, Y. J., Huang, L. C., Romanowski, E. G., Yates, K. A., Proske, R. J., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590934111 · Cited by 252
Direct evidence of bacterial biofilms in otitis media
Post, J. C. (2015) · The Laryngoscope · doi:10.1002/lary.25291 · Cited by 249
Bazaka, K., Jacob, M. V., Crawford, R. J., & Ivanova, E. P. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4144-7 · Cited by 246
Candidate's Thesis: Direct Evidence of Bacterial Biofilms in Otitis Media
Post, J. C. (2001) · The Laryngoscope · doi:10.1097/00005537-200112000-00001 · Cited by 243
Guilhen, C., Forestier, C., & Balestrino, D. (2017) · Molecular Microbiology · doi:10.1111/mmi.13698 · Cited by 228
Antibiotic action of pyocyanin
Baron, S. S., & Rowe, J. J. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.6.814 · Cited by 226
Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm
Wei, G.-X. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl120 · Cited by 222
Schaumberger, S., Ladinig, A., Reisinger, N., Ritzmann, M., & Schatzmayr, G. (2014) · AMB Express · doi:10.1186/2191-0855-4-1 · Cited by 219
Harrison, J. J., Turner, R. J., & Ceri, H. (2005) · Environmental Microbiology · doi:10.1111/j.1462-2920.2005.00777.x · Cited by 214
GlpD and PlsB Participate in Persister Cell Formation in Escherichia coli
Spoering, A. L., Vulić, M., & Lewis, K. (2006) · Journal of Bacteriology · doi:10.1128/jb.00369-06 · Cited by 214
Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions
Machado, D., Castro, J., Palmeira-de-Oliveira, A., Martinez-de-Oliveira, J., & Cerca, N. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01528 · Cited by 213
Nitric oxide-releasing sol–gels as antibacterial coatings for orthopedic implants
Nablo, B. J., Rothrock, A. R., & Schoenfisch, M. H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.03.031 · Cited by 207
Lipids and Essential Oils as Antimicrobial Agents
(2011) · Wiley eBooks · doi:10.1002/9780470976623 · Cited by 202
Glycerol monolaurate antibacterial activity in broth and biofilm cultures.
Schlievert, P. M., & Peterson, M. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040350 · Cited by 198
Combatting bacterial infections by killing persister cells with mitomycin C
Kwan, B. W., Chowdhury, N., & Wood, T. K. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.12873 · Cited by 193
Potential Applications of Antimicrobial Fatty Acids in Medicine, Agriculture and Other Industries
P. Desbois, A. (2012) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489112801619728 · Cited by 192
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Bagge, N., Hentzer, M., Andersen, J. B., Ciofu, O., Givskov, M., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1168-1174.2004 · Cited by 192
Antimicrobial Peptides – Promising Alternatives to Conventional Antibiotics
Baltzer, S. A., & Brown, M. H. (2011) · Microbial Physiology · doi:10.1159/000331009 · Cited by 191
Luppens, S. B. I., Reij, M. W., van der Heijden, R. W. L., Rombouts, F. M., & Abee, T. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.9.4194-4200.2002 · Cited by 189
Delcaru, C., Alexandru, I., Podgoreanu, P., Grosu, M., Stavropoulos, E., Chifiriuc, M., & Lazar, V. (2016) · Pathogens · doi:10.3390/pathogens5040065 · Cited by 189
The Consequences of Biofilm Dispersal on the Host
Fleming, D., & Rumbaugh, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-29121-2 · Cited by 186
Identification of Pseudomonas aeruginosa Phenazines that Kill Caenorhabditis elegans
Cezairliyan, B., Vinayavekhin, N., Grenfell-Lee, D., Yuen, G. J., Saghatelian, A., & Ausubel, F. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003101 · Cited by 182
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma
Shields, C. L., Naseripour, M., & Shields, J. A. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01400-9 · Cited by 181
Scientific Status Summary: Quorum Sensing in Biofilms: Why Bacteria Behave the Way They Do
Annous, B. A., Fratamico, P. M., & Smith, J. L. (2009) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.01022.x · Cited by 181
Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
Belley, A., Neesham-Grenon, E., McKay, G., Arhin, F. F., Harris, R., Beveridge, T., Parr, T. R., & Moeck, G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-08 · Cited by 178
The chemistry and biology of LL-37
Burton, M. F., & Steel, P. G. (2009) · Natural Product Reports · doi:10.1039/b912533g · Cited by 173
Yang, Y., Lii, C., Wei, Y., Li, C., Lu, C., Liu, K., & Chen, H. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.05.003 · Cited by 159
Cephalosporin‐3′‐diazeniumdiolates: Targeted NO‐Donor Prodrugs for Dispersing Bacterial Biofilms
Barraud, N., Kardak, B. G., Yepuri, N. R., Howlin, R. P., Webb, J. S., Faust, S. N., Kjelleberg, S., Rice, S. A., & Kelso, M. J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202414 · Cited by 158
Adaptive responses to antimicrobial agents in biofilms.
Szomolay, B., Klapper, I., Dockery, J., & Stewart, P. S. (2005) · Environmental Microbiology · doi:10.1111/j.1462-2920.2005.00797.x · Cited by 158
Jennings, M. C., Ator, L. E., Paniak, T. J., Minbiole, K. P. C., & Wuest, W. M. (2014) · ChemBioChem · doi:10.1002/cbic.201402254 · Cited by 153
Karatuna, O., & Yağcı, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03177.x · Cited by 152
Beckloff, N., Laube, D. M., Castro, T. A., Furgang, D., Park, S., Perlin, D. S., Clements, D. J., Tang, H., Scott, R. W., Tew, G. N., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00208-07 · Cited by 143
Combination Antimicrobial Therapy for Bacterial Infections
Rybak, M. J., & McGrath, B. J. (1996) · Drugs · doi:10.2165/00003495-199652030-00005 · Cited by 139
Slimy business—the biotechnology of biofilms
Schachter, B. S. (2003) · Nature Biotechnology · doi:10.1038/nbt0403-361 · Cited by 131
DNA‐crosslinker cisplatin eradicates bacterial persister cells
Chowdhury, N., Wood, T. L., Martínez‐Vázquez, M., García‐Contreras, R., & Wood, T. K. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25963 · Cited by 127
Microbial Biofilms in Ophthalmology and Infectious Disease
Behlau, I., & Gilmore, M. S. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.11.1572 · Cited by 125
Transfer of antibiotic resistance by transformation with eDNA within oral biofilms
Hannan, S., Ready, D., Jasni, A. S., Rogers, M., Pratten, J., & Roberts, A. P. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00661.x · Cited by 125
Persister cells mediate tolerance to metal oxyanions in Escherichia coli
Harrison, J. J., Ceri, H., Roper, N. J., Badry, E. A., Sproule-Willoughby, K. M., & Turner, R. J. (2005) · Microbiology · doi:10.1099/mic.0.27794-0 · Cited by 119
Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
Kang, J. H., Dietz, M. J., & Li, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216676 · Cited by 118
Mitomycin: ten years after approval for marketing.
Doll, D. C., Weiss, R. B., & Issell, B. F. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.2.276 · Cited by 111
Hell, É., Giske, C. G., Nelson, A., Römling, U., & Marchini, G. (2009) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2009.02778.x · Cited by 107
Tetracycline Rapidly Reaches All the Constituent Cells of Uropathogenic Escherichia coli Biofilms
Stone, G., Wood, P., Dixon, L., Keyhan, M., & Matin, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2458-2461.2002 · Cited by 105
Farrell, D. J., Robbins, M. J., Rhys‐Williams, W., & Love, W. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01285-10 · Cited by 98
Microbial biofilms and gastrointestinal diseases
von Rosenvinge, E. C., O’May, G. A., Macfarlane, S., Macfarlane, G. T., & Shirtliff, M. E. (2012) · Pathogens and Disease · doi:10.1111/2049-632x.12020 · Cited by 97
Microbiology of early CF lung disease
Saiman, L. M. (2004) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0542(04)90065-6 · Cited by 95
Ooi, N., Miller, K., Randall, C. P., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp409 · Cited by 94
β-Lactam induction of colanic acid gene expression inEscherichia coli
Sailer, F. C., Meberg, B. M., & Young, K. D. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00616-5 · Cited by 92
Garrison, A. T., Abouelhassan, Y., Kallifidas, D., Bai, F., Ukhanova, M., Mai, V., Jin, S., Luesch, H., & Huigens, R. W. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508155 · Cited by 90
Flemming, K., Klingenberg, C., Cavanagh, J. P., Sletteng, M., Stensen, W., Svendsen, J. S. M., & Flægstad, T. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn464 · Cited by 90
de la Fuente‐Núñez, C., Reffuveille, F., Fairfull‐Smith, K. E., & Hancock, R. E. W. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01381-13 · Cited by 90
Self-citationSun, M., Zhou, Z., Dong, J., Zhang, J., Xia, Y., & Shu, R. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.08.025 · Cited by 90
Cruz-Muñiz, M. Y., López-Jácome, L. E., Hernández-Durán, M., Franco‐Cendejas, R., Licona-Limón, P., Ramos-Balderas, J. L., Martínez‐Vázquez, M., Belmont-Díaz, J., Wood, T. K., & García‐Contreras, R. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.022 · Cited by 87
Divalent Metal Cations Increase the Activity of the Antimicrobial Peptide Kappacin
Dashper, S. G., O’brien-simpson, N. M., Cross, K. J., Paolini, R. A., Hoffmann, B., Catmull, D. V., Malkoski, M., & Reynolds, E. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2322-2328.2005 · Cited by 86
Worley, B. V., Schilly, K. M., & Schoenfisch, M. H. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00006 · Cited by 83
Abouelhassan, Y., Garrison, A. T., Burch, G. M., Wong, W., Norwood, V. M., & Huigens, R. W. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.009 · Cited by 76
Eckert, R., Brady, K. M., Greenberg, E. P., Qi, F., Yarbrough, D. K., He, J. G., McHardy, I. H., Anderson, M. H., & Shi, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-06 · Cited by 74
Field, T. R., White, A. P., Elborn, J. S., & Tunney, M. M. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0031-9 · Cited by 67
Davenport, E. K., Call, D., & Beyenal, H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03071-14 · Cited by 65
Antimicrobial dendrimer active against Escherichia coli biofilms
Hou, S., Zhou, C., Liu, Z., Young, A. W., Shi, Z., Ren, D., & Kallenbach, N. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.077 · Cited by 60
Yepuri, N. R., Barraud, N., Mohammadi, N. S., Kardak, B. G., Kjelleberg, S. J., Rice, S. A., & Kelso, M. J. (2013) · Chemical Communications · doi:10.1039/c3cc40869h · Cited by 53
Ciprofloxacin-nitroxide hybrids with potential for biofilm control
Verderosa, A. D., de la Fuente‐Núñez, C., Mansour, S., Cao, J., Lu, T. K., Hancock, R. E. W., & Fairfull‐Smith, K. E. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.058 · Cited by 52
Self-citationMarvasi, M., Chen, C., Carrazana, M., Durie, I. A., & Teplitski, M. (2014) · AMB Express · doi:10.1186/s13568-014-0042-y · Cited by 50
Sun, M., Dong, J., Xia, Y., & Shu, R. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.03.040 · Cited by 50
Farrell, D. J., Robbins, M. J., Rhys‐Williams, W., & Love, W. G. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.02.008 · Cited by 47
From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Phenazine Antibiotic‐Inspired Discovery of Bacterial Biofilm‐Eradicating Agents
Huigens, R. W., Abouelhassan, Y., & Yang, H. (2019) · ChemBioChem · doi:10.1002/cbic.201900116 · Cited by 46
Potentiation of ciprofloxacin action against Gram-negative bacterial biofilms by a nitroxide
Reffuveille, F., de la Fuente‐Núñez, C., Fairfull‐Smith, K. E., & Hancock, R. E. W. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv016 · Cited by 44
Self-citationHou, S., Liu, Z., Young, A. W., Mark, S. L., Kallenbach, N. R., & Ren, D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02321-09 · Cited by 44
Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents
Verderosa, A. D., Mansour, S., de la Fuente‐Núñez, C., Hancock, R. E. W., & Fairfull‐Smith, K. E. (2016) · Molecules · doi:10.3390/molecules21070841 · Cited by 43
Self-citationBasak, A. K., Abouelhassan, Y., & Huigens, R. W. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01883h · Cited by 37
Basak, A. K., Abouelhassan, Y., Norwood, V. M., Bai, F., Nguyen, M. T., Jin, S., & Huigens, R. W. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600926 · Cited by 37
Verderosa, A. D., Dhouib, R., Fairfull‐Smith, K. E., & Totsika, M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01685-19 · Cited by 37
Self-citationDifferent effects of omega-3 fatty acids on the cell cycle in c2c12 myoblast proliferation
Peng, Y., Zheng, Y., Zhang, Y., Zhao, J., Chang, F., Lu, T., Zhang, R., Li, Q., Hu, X., & Li, N. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1329-4 · Cited by 34
Polynitroxide copolymers to reduce biofilm fouling on surfaces
Boase, N. R. B., Torres, M. D. T., Fletcher, N. L., de la Fuente‐Núñez, C., & Fairfull‐Smith, K. E. (2018) · Polymer Chemistry · doi:10.1039/c8py01101j · Cited by 31
Self-citationEradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin–dinitroxide conjugate
Verderosa, A. D., Harris, J., Dhouib, R., Totsika, M., & Fairfull‐Smith, K. E. (2019) · MedChemComm · doi:10.1039/c9md00062c · Cited by 23
Self-citationYendewa, G. A., Griffiss, J. M., Jacobs, M. R., Fulton, S. A., O’Riordan, M. A., Gray, W. A., Proskin, H. M., Winkle, P. J., & Salata, R. A. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.09.017 · Cited by 23
Controlling biofilm formation with nitroxide functional surfaces
Woehlk, H., Trimble, M. J., Mansour, S., Pletzer, D., Trouillet, V., Welle, A., Barner, L., Hancock, R. E. W., Barner‐Kowollik, C., & Fairfull‐Smith, K. E. (2019) · Polymer Chemistry · doi:10.1039/c9py00690g · Cited by 22
Self-citationRedelman, C. V., Chakravarty, S., & Anderson, G. G. (2013) · Microbiology · doi:10.1099/mic.0.070144-0 · Cited by 21
Zhao, J., Jiang, H., Cheng, W., Wu, J., Zhao, J., Wang, J., & Dong, L. (2014) · Journal of Basic Microbiology · doi:10.1002/jobm.201300987 · Cited by 18
Cited by
The Role of Bacterial Biofilm in Antibiotic Resistance and Food Contamination
Abebe, G. M. (2020) · International Journal of Microbiology · doi:10.1155/2020/1705814 · Cited by 406
Srinivasan, R., Santhakumari, S., Poonguzhali, P., Geetha, M., Dyavaiah, M., & Xiangmin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676458 · Cited by 352
Microtiter plate assays to assess antibiofilm activity against bacteria
Haney, E. F., Trimble, M. J., & Hancock, R. E. W. (2021) · Nature Protocols · doi:10.1038/s41596-021-00515-3 · Cited by 295
Challenges of antibiotic resistance biofilms and potential combating strategies: a review
Khan, J., Tarar, S. M., Gul, I., Nawaz, U., & Arshad, M. (2021) · 3 Biotech · doi:10.1007/s13205-021-02707-w · Cited by 172
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Metadata
- Authors
- Verderosa, A. D., Totsika, M., & Fairfull-Smith, K. E.
- Venue
- Frontiers in Chemistry
- Publisher
- Frontiers Media SA
- Published
- 2019-11-28
- Volume
- 7
- Pages
- 824-824
- ISSN
- 2296-2646 (ISSN-L)
- OpenAlex
- W2991280282
- Cited by
- 555
- References
- 157
- FWCI
- 18.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.